Gerard Griffioen
Technik-/Wissenschafts-/F&E-Leiter bei reMYND NV
Aktive Positionen von Gerard Griffioen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
reMYND NV
 reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Karriereverlauf von Gerard Griffioen
Ehemalige bekannte Positionen von Gerard Griffioen
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Katholieke Universiteit Leuven | Corporate Officer/Principal | - | - |
| University of Vienna | Corporate Officer/Principal | - | - |
Ausbildung von Gerard Griffioen
| Vrije Universiteit Amsterdam | Doctorate Degree |
Statistik
International
| Belgien | 3 |
| Vereinigtes Königreich | 2 |
| Österreich | 2 |
Operativ
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Doctorate Degree | 1 |
Sektoral
| Consumer Services | 4 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
reMYND NV
reMYND NV Miscellaneous Commercial ServicesCommercial Services reMYND NV engages in the development of disease-modifying treatments against alzheimer's, parkinson's, diabetes and other protein misfolding disorders. Its drug and development unit focuses on innovative, disease-modifying drugs for treating degenerative disorders. The company was founded by Fred Van Leuven, Stefaan Wera and Joris Winderickx in 2002 and is headquartered in Leuven, Belgium. | Commercial Services |
- Börse
- Insiders
- Gerard Griffioen
- Erfahrung
